You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Inluriyo ™ (imlunestrant) tablets
200 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How should Inluriyo™ (imlunestrant) tablets be stored?
Store Inluriyo (imlunestrant) tablets at 68°F to 77°F (20°C to 25°C). Excursions between 59°F to 86°F (15°C to 30°C) are permitted.
Dosage Form
Imlunestrant 200 mg tablet is a white capsule-shaped, film coated-capsule shaped tablet with
- "LILLY" on one side, and
- an elongated 4-point starburst and "1717" on the other side.1
Packaging Configuration
Imlunestrant 200 mg tablets are supplied in either a 28-count or 56-count bottle configuration:
- 28-count: NDC 0002-1717-28, and
- 56-count: NDC 0002-1717-56.1
Storage Conditions
Store imlunestrant tablets at 68°F to 77°F (20°C to 25°C). Excursions between 59°F to 86°F (15°C to 30°C) are permitted.1
Disposal
Dispose unused imlunestrant tablets via a take-back option if available. Otherwise, follow FDA instructions for disposing medication in the household trash, www.fda.gov/drugdisposal. Do NOT flush down the toilet.1
Enclosed Prescribing Information
Reference
1Inluriyo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2025.
Date of Last Review: July 16, 2025